Hikma Pharmaceuticals PLC (LON:HIK)
London
· Delayed Price · Currency is GBP · Price in GBp 2,026.00
+27.00 (1.35%)
Jun 27, 2025, 5:49 PM BST
Hikma Pharmaceuticals Ratios and Metrics
Market cap in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 27, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 4,554 | 4,419 | 3,955 | 3,418 | 5,136 | 5,803 | Upgrade
| |
Market Cap Growth | 11.74% | 11.74% | 15.72% | -33.45% | -11.50% | 20.30% | Upgrade
|
Enterprise Value | 5,436 | 5,234 | 4,766 | 4,383 | 5,569 | 6,208 | Upgrade
|
Last Close Price | 20.66 | 19.58 | 17.03 | 14.38 | 20.08 | 22.42 | Upgrade
|
PE Ratio | 16.07 | 15.41 | 26.52 | 21.91 | 16.52 | 18.38 | Upgrade
|
Forward PE | 12.06 | 10.90 | 10.80 | 9.65 | 14.20 | 18.48 | Upgrade
|
PS Ratio | 1.82 | 1.77 | 1.75 | 1.64 | 2.72 | 3.38 | Upgrade
|
PB Ratio | 2.46 | 2.38 | 2.28 | 1.92 | 2.82 | 3.69 | Upgrade
|
P/TBV Ratio | 4.94 | 4.79 | 4.59 | 4.07 | 4.46 | 6.29 | Upgrade
|
P/FCF Ratio | 14.29 | 13.87 | 11.48 | 10.51 | 14.11 | 27.13 | Upgrade
|
P/OCF Ratio | 10.11 | 9.81 | 8.29 | 7.77 | 10.90 | 17.08 | Upgrade
|
PEG Ratio | 1.17 | 1.66 | 1.55 | 2.10 | 1.49 | 2.02 | Upgrade
|
EV/Sales Ratio | 2.18 | 2.10 | 2.11 | 2.10 | 2.95 | 3.62 | Upgrade
|
EV/EBITDA Ratio | 8.53 | 8.33 | 7.62 | 7.88 | 10.50 | 12.96 | Upgrade
|
EV/EBIT Ratio | 11.17 | 10.78 | 9.71 | 10.61 | 13.44 | 15.70 | Upgrade
|
EV/FCF Ratio | 17.06 | 16.42 | 13.83 | 13.47 | 15.30 | 29.03 | Upgrade
|
Debt / Equity Ratio | 0.56 | 0.56 | 0.54 | 0.60 | 0.34 | 0.43 | Upgrade
|
Debt / EBITDA Ratio | 1.64 | 1.64 | 1.46 | 1.88 | 1.16 | 1.40 | Upgrade
|
Debt / FCF Ratio | 3.27 | 3.27 | 2.71 | 3.27 | 1.72 | 3.19 | Upgrade
|
Asset Turnover | 0.64 | 0.64 | 0.63 | 0.57 | 0.60 | 0.58 | Upgrade
|
Inventory Turnover | 1.82 | 1.82 | 1.76 | 1.70 | 1.73 | 1.70 | Upgrade
|
Quick Ratio | 0.60 | 0.60 | 0.82 | 1.05 | 1.31 | 1.05 | Upgrade
|
Current Ratio | 1.14 | 1.14 | 1.57 | 1.86 | 2.06 | 1.87 | Upgrade
|
Return on Equity (ROE) | 15.98% | 15.98% | 8.81% | 8.28% | 18.20% | 20.11% | Upgrade
|
Return on Assets (ROA) | 7.75% | 7.75% | 8.54% | 7.04% | 8.24% | 8.37% | Upgrade
|
Return on Capital (ROIC) | 10.81% | 10.81% | 11.44% | 9.23% | 10.97% | 11.45% | Upgrade
|
Return on Capital Employed (ROCE) | 19.30% | 19.30% | 18.70% | 14.70% | 16.70% | 17.40% | Upgrade
|
Earnings Yield | 6.30% | 6.49% | 3.77% | 4.57% | 6.05% | 5.44% | Upgrade
|
FCF Yield | 7.00% | 7.21% | 8.71% | 9.52% | 7.09% | 3.69% | Upgrade
|
Dividend Yield | 2.85% | 3.26% | 3.32% | 3.23% | 1.99% | 1.63% | Upgrade
|
Payout Ratio | 48.75% | 48.75% | 72.10% | 66.49% | 28.50% | 25.29% | Upgrade
|
Buyback Yield / Dilution | -0.51% | -0.51% | 1.13% | 3.47% | 2.10% | 2.06% | Upgrade
|
Total Shareholder Return | 2.41% | 2.76% | 4.45% | 6.70% | 4.09% | 3.69% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.